Analystreport

CytomX Therapeutics, Inc. (NASDAQ: CTMX) had its price target lowered by analysts at Piper Sandler from $16.00 to $10.00.

CytomX Therapeutics, Inc.  (CTMX) 
Last cytomx therapeutics, inc. earnings: 11/7 04:09 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cytomx.com